ES2077345T3 - INTERMEDIARIES OF THE MUREIDOMICINA GROUP, ITS PREPARATION AND USE. - Google Patents
INTERMEDIARIES OF THE MUREIDOMICINA GROUP, ITS PREPARATION AND USE.Info
- Publication number
- ES2077345T3 ES2077345T3 ES92202494T ES92202494T ES2077345T3 ES 2077345 T3 ES2077345 T3 ES 2077345T3 ES 92202494 T ES92202494 T ES 92202494T ES 92202494 T ES92202494 T ES 92202494T ES 2077345 T3 ES2077345 T3 ES 2077345T3
- Authority
- ES
- Spain
- Prior art keywords
- group
- carbon atoms
- mureidomycin
- compound
- tetrahydroisoquinolin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0217—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -C(=O)-C-N-C(=O)-N-C-C(=O)-
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Compounds Of Unknown Constitution (AREA)
Abstract
New antibiotics of the mureidomycin group have the formula <CHEM> wherein X represents the group <CHEM> and wherein R represents a hydrogen atom, an alkyl group having from 1 to 10 carbon atoms, an alkenyl group having from 2 to 7 carbon atoms, an alkynyl group having from 3 to 7 carbon atoms, an aryl group having from 6 to 10 carbon atoms, an aralkyl group having from 7 to 10 carbon atoms, or one of the said aryl or aralkyl groups substituted with at least one halogen atom and/or at least least one alkyl group having from 1 to 5 carbon atoms. The compound in which X represents 8-hydroxy-1,2,3,4-tetrahydroisoquinolin-3-yl is named mureidomycin E and the compound in which X represents 6-hydroxy-1,2,3,4-tetrahydroisoquinolin-3-yl is named mureidomycin F. This group of compounds and their pharmaceutically acceptable esters and salts are useful as antibiotics for the treatment of bacterial infections. Mureidomycins E and F can be obtained by fermentation of a suitable Streptomyces strain, in particular Streptomyces flavidovirens SANK 60486 (BIKOKEN JOHKI 1347; FERM BP-1347). ALternatively, all of the compounds can be obtained synthetically by reacting the previously known compound mureidomycin A with an aldehyde of the formula R - CHO.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP29335387 | 1987-11-20 | ||
JP29335287 | 1987-11-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2077345T3 true ES2077345T3 (en) | 1995-11-16 |
Family
ID=26559375
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES88310822T Expired - Lifetime ES2054829T3 (en) | 1987-11-20 | 1988-11-16 | ANTIBIOTICS OF THE MUREIDOMICINA GROUP, ITS PREPARATION AND ITS USE. |
ES92202494T Expired - Lifetime ES2077345T3 (en) | 1987-11-20 | 1988-11-16 | INTERMEDIARIES OF THE MUREIDOMICINA GROUP, ITS PREPARATION AND USE. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES88310822T Expired - Lifetime ES2054829T3 (en) | 1987-11-20 | 1988-11-16 | ANTIBIOTICS OF THE MUREIDOMICINA GROUP, ITS PREPARATION AND ITS USE. |
Country Status (8)
Country | Link |
---|---|
US (1) | US5041423A (en) |
EP (2) | EP0517345B1 (en) |
KR (2) | KR0137779B1 (en) |
AT (1) | ATE125256T1 (en) |
CA (1) | CA1339595C (en) |
DE (2) | DE3880092T2 (en) |
ES (2) | ES2054829T3 (en) |
HK (2) | HK1003573A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0487756A1 (en) * | 1990-11-26 | 1992-06-03 | Hoechst Aktiengesellschaft | Antibiotics napsamycins A-D, process for their production and their use as pharmaceuticals |
US6228842B1 (en) | 1998-11-06 | 2001-05-08 | Microcide Pharmaceuticals, Inc. | Pacidamycins produced by Streptomyces coeruleorubidus |
US6482921B1 (en) * | 1999-01-28 | 2002-11-19 | Essential Therapeutics, Inc. | Uridyl peptide antibiotic (UPA) derivatives, their synthesis and use |
SI1430138T1 (en) * | 2001-09-27 | 2006-04-30 | Biocon Ltd | Process for producing pravastatin sodium salt using streptomyces flavidovirens dsm 14455 |
KR102302414B1 (en) | 2014-06-20 | 2021-09-16 | 주식회사 만도 | Ground connectin structure between pcb and chassia for reducing impedance |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3341571A1 (en) * | 1983-11-17 | 1985-05-30 | Bayer Ag, 5090 Leverkusen | NEW ANTIBIOTICS, METHOD FOR THEIR PRODUCTION, THEIR USE AS MEDICINAL PRODUCTS AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION |
GB8421279D0 (en) * | 1984-08-22 | 1984-09-26 | Baldwin J E | Antibiotics |
IT1184164B (en) * | 1985-03-19 | 1987-10-22 | Eniricerche Spa | TRIPTIDES WITH HYPOTHENSIVE ACTION AND PROCEDURE FOR THEIR SYNTHESIS |
CA1339467C (en) * | 1986-05-20 | 1997-09-16 | Keiko Shimizu | New antibiotics called "mureidomycins a, b, c and d", a process for their preparation and their therapeutic use |
-
1988
- 1988-11-16 EP EP92202494A patent/EP0517345B1/en not_active Expired - Lifetime
- 1988-11-16 AT AT92202494T patent/ATE125256T1/en not_active IP Right Cessation
- 1988-11-16 DE DE88310822T patent/DE3880092T2/en not_active Expired - Fee Related
- 1988-11-16 ES ES88310822T patent/ES2054829T3/en not_active Expired - Lifetime
- 1988-11-16 ES ES92202494T patent/ES2077345T3/en not_active Expired - Lifetime
- 1988-11-16 DE DE3854205T patent/DE3854205T2/en not_active Expired - Fee Related
- 1988-11-16 EP EP88310822A patent/EP0317292B1/en not_active Expired - Lifetime
- 1988-11-17 US US07/273,199 patent/US5041423A/en not_active Expired - Fee Related
- 1988-11-19 KR KR1019880015272A patent/KR0137779B1/en not_active IP Right Cessation
- 1988-11-21 CA CA000583649A patent/CA1339595C/en not_active Expired - Fee Related
-
1997
- 1997-10-13 KR KR1019970056329A patent/KR0137675B1/en not_active IP Right Cessation
-
1998
- 1998-03-30 HK HK98102695A patent/HK1003573A1/en not_active IP Right Cessation
- 1998-06-03 HK HK98104839A patent/HK1005736A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE3854205D1 (en) | 1995-08-24 |
EP0317292A3 (en) | 1990-07-25 |
HK1003573A1 (en) | 1998-10-30 |
EP0517345A1 (en) | 1992-12-09 |
ES2054829T3 (en) | 1994-08-16 |
DE3854205T2 (en) | 1996-04-04 |
ATE125256T1 (en) | 1995-08-15 |
KR890008130A (en) | 1989-07-08 |
DE3880092T2 (en) | 1993-11-25 |
HK1005736A1 (en) | 1999-01-22 |
KR0137675B1 (en) | 1998-05-15 |
CA1339595C (en) | 1997-12-23 |
EP0317292B1 (en) | 1993-04-07 |
US5041423A (en) | 1991-08-20 |
EP0517345B1 (en) | 1995-07-19 |
KR0137779B1 (en) | 1998-05-15 |
DE3880092D1 (en) | 1993-05-13 |
EP0317292A2 (en) | 1989-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU557691B2 (en) | 2-penem antibiotics and their oxa-aza-, and carba analogues | |
ATE89822T1 (en) | HETEROCYCLIC DERIVATIVES SUBSTITUTED BY BENZHYDRYL N, THEIR PRODUCTION AND USE. | |
PT83843B (en) | PROCESS FOR THE PREPARATION OF RAPAMICINE AVERAGES | |
AU8682191A (en) | Azasteroid compounds for the treatment of prostatic hypertrophy, their preparation and use | |
DK0615549T3 (en) | Process for the preparation of pharmaceutically active thiazolidine or oxazolidine compounds with a yeast reductase | |
FI911016A0 (en) | Process for the preparation of pharmacologically active substituted diketones | |
ES2077345T3 (en) | INTERMEDIARIES OF THE MUREIDOMICINA GROUP, ITS PREPARATION AND USE. | |
ES8506731A1 (en) | Cephalosporin derivatives. | |
ZA894470B (en) | Substituted 3-aminosydnone imines,a process for their preparation and their use | |
PT99250A (en) | PROCESS FOR THE PREPARATION OF PIPERAZINE DERIVATIVES | |
EP0367036A3 (en) | Substituted 3-aminosydnonimines, process for their preparation and their use | |
ES2026548T3 (en) | A PROCEDURE FOR PREPARING PENEMOS. | |
FI943596A (en) | A process for the preparation of therapeutically useful macrolide compounds | |
NO167382C (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 4-HYDROXY-4- (SUBSTITUTED ALKENYL) CYCLOHEXANCARBOXYL ACIDS. | |
CA1268121C (en) | .alpha.-ALKYL POLYOLEFINIC CARBOXYLIC ACIDS AND DERIVATIVES THEREOF USEFUL IN THE TREATMENT OF PSORIASIS AND ALLERGIC RESPONSES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 517345 Country of ref document: ES |